Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
eClinical Solutions Market by Product (CDMS, eCOA, CTMS, RTSM, ETMF, Analytics, Safety), Delivery (Web-hosted, Licensed Enterprise, Cloud-based), End User (Pharma, Hospitals, CROs), Clinical Trial Phases (Phase I, II) & Region - Global Forecasts to 2027
... The global eClinical Solutions market is projected to reach USD 17.9 billion in 2027 from USD 9.6 billion in 2022 at a CAGR of 13.3%. Rising operational costs and regulatory requirements pertaining to clinical research ... Read More
-
Global Healthcare Digital Twins Market Size study & Forecast, by Type (Process & System Digital Twin, Product Digital Twin) by Application (Asset and Process Management, Personalized Medicine, Drug Discovery, Others), by End Use (Clinical Research Organizations (CRO), Hospitals and Clinics, Research & Diagnostic Laboratories, Others) and Regional Analysis, 2022-2029
... Organizations (CRO), Hospitals and Clinics, Research & Diagnostic Laboratories, Others) and Regional Analysis, 2022-2029 Global Healthcare Digital Twins Market is valued at approximately USD 462.6 million in 2021 and is anticipated to grow with a ... Read More
-
Global Congestive Heart Failure Drugs Market Size study & Forecast, by Type (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029
... Regional Analysis, 2022-2029 Global Congestive Heart Failure Drugs Market is valued at approximately USD 6.15 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.60% over the forecast ... Read More
-
Ovarian Cancer Drugs Global Market Opportunities and Strategies To 2031
... information they need to assess the global ovarian cancer drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this ... Read More
-
Ophthalmology Drugs Global Market Opportunities And Strategies To 2031
... need to assess the global ophthalmology drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 50 ... Read More
-
Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2027
... projected to reach USD 27.0 billion by 2027 from USD 13.0 billion in 2022, at a CAGR of 15.7% during the forecast period of 2022 to 2027. Increasing applications of NGS in cancer research, growing ... Read More
-
Biopreservation Market Analysis And Forecast To 2032: By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine, Bio-banking, Drug Discovery), By Cell Providers Volume (CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells, Others), And Region
... is a technique for preserving cells, organs, and tissues outside the natural environment to extend shelf life and to ensure the stability and purity of cells, organ, and tissues. Bio-preservation plays a key role in ... Read More
-
Global Glaucoma Therapeutics Market Size study & Forecast, by Drug Class (Beta Blockers, Prostaglandins Analogs, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs), By Disease Indication (Open Angle Glaucoma, Angle Closure Glaucoma) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029
... (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029 Global Glaucoma Therapeutics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Metagenomics Market Size study & Forecast, by Technology ( Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing and Others) by Product (Kits and Reagents, Sequencing & Data Analytics Services, Software), by Application ( Environmental Application, Clinical Diagnostics Applications, Drug Discovery Applications, Biotechnology Applications, Food & Nutrition Applications and Other Application), by Workflow (Pre-sequencing, Sequencing and Data Analysis) and Regional Analysis, 2022-2029
... Clinical Diagnostics Applications, Drug Discovery Applications, Biotechnology Applications, Food & Nutrition Applications and Other Application), by Workflow (Pre-sequencing, Sequencing and Data Analysis) and Regional Analysis, 2022-2029 Global Metagenomics Market is valued approximately USD 1.46 billion ... Read More
-
Global Stem Cells Market Size study & Forecast, by Product (Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), By Therapy (Autologous, Allogenic), By Application (Regenerative Medicine, Drug Discovery and Development), By End-user (Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes), and Regional Analysis, 2022-2029
... Production, Cryopreservation, Expansion and Sub-Culture), By Therapy (Autologous, Allogenic), By Application (Regenerative Medicine, Drug Discovery and Development), By End-user (Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes), and Regional Analysis, 2022-2029 ... Read More
-
DTP Vaccines Global Market Opportunities And Strategies To 2031
... need to assess the global DTP Vaccines market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering ... Read More
-
Paroxysmal Nocturnal Hemoglobinuria (PNH) - Drug Pipeline Landscape, 2023
... Hemoglobinuria symptoms includes abdominal pain, back pain, dark urine, easy bruising or bleeding, headache, and shortness of breath. Paroxysmal Nocturnal Hemoglobinuria is diagnosed by tests like flow cytometry, a blood test that identifies blood cells ... Read More
-
Microbiome Therapeutics: Global Markets
... Inc. Pylum Biosciences Inc. Quorum Innovations Llc Rebiotix Inc. (A Ferring Company) Second Genome Senda Biosciences Inc. Seres Therapeutics Inc. Sfa Therapeutics Inc. Synlogic Theriva Biologics Inc. Vedanta Biosciences Inc. Ysopia Bioscience Inc.Report Scope: BCC ... Read More
-
Virus-Like Particles (VLP’s) Market Analysis And Forecast To 2032: By Product Type (Hepatitis, Cancer/HPV, Gaucher Disease), Source (Yeast, Insect Cell, Plant, Others), Application (Vaccine, Therapeutics), And Region
... period. Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccine candidates. Market Trends and Drivers Consistent R&D ... Read More
-
Global Gastrointestinal Rare Diseases Treatment Market Growth (Status and Outlook) 2023-2029
... Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Rare Diseases Treatment sales for 2023 through 2029. With Gastrointestinal Rare Diseases Treatment sales broken down by region, market ... Read More
-
Global Soft Tissue Sarcoma Drugs Market Growth (Status and Outlook) 2023-2029
... Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Soft Tissue Sarcoma Drugs sales for 2023 through 2029. With Soft Tissue Sarcoma Drugs sales broken down by region, market ... Read More
-
Rare Disease Treatment Market Size By Drug (Biologics, Non-biologics), By Therapeutic Area (Cancer, Blood-related Disorders, Central Nervous System (CNS), Respiratory Disorders, Musculoskeletal Disorders, Cardiovascular Disorders), By Patient (Adult, Pediatric), By Route of Administration (Oral, Injectable), Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032
... Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032 Rare Disease Treatment Market is anticipated to grow considerably through 2032 owing to the increasing prevalence of rare diseases across ... Read More
-
Gastroesophageal Reflux Disease (GERD) - Drug Pipeline Landscape, 2023
... erosions. Gastroesophageal reflux disease can cause due to frequent acid reflux or reflux of nonacidic content from the stomach, If the sphincter does not relax as it should or it weakens, stomach acid can flow ... Read More
-
Frontal Fibrosing Alopecia
... Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable ... Read More
-
Ophthalmology Drugs Global Market Briefing 2023
... market was $7.2 and in terms of global GDP, the market was 0.05%. Ophthalmology drugs was the ninth largest segment within the market accounting for 3.5% preceded and followed by gastrointestinal drugs and at 4.7% ... Read More
-
Pharmaceuticals Global Market Briefing 2023
... drugs was the largest segment within the pharmaceuticals market accounting for 15.5% followed by oncology drugs at 13.9% and central nervous system drugs at 11.2%. Pharmaceuticals Global Market Briefing 2023 provides strategists, marketers and senior ... Read More
-
Oncology Drugs Global Market Briefing 2023
... market was $28.5 and in terms of global GDP, the market was 0.20%. Oncology drugs was the second largest segment within the market accounting for 13.9% preceded and followed by anti-infective drugs at 15.5% and ... Read More
-
Cardiovascular Drugs Global Market Briefing 2023
... market was $19.8 and in terms of global GDP, the market was 0.14%. Cardiovascular drugs was the fifth largest segment within the market accounting for 9.6% preceded and followed by respiratory diseases drugs at 9.7% ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2023
... consumption, the market was $11.7 and in terms of global GDP, the market was 0.08%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.7% preceded and followed by musculoskeletal disorders ... Read More
-
Anti-Infective Drugs Global Market Briefing 2023
... was $31.8 and in terms of global GDP, the market was 0.23%. Anti-infective drugs was the largest segment within the market accounting for 15.5% followed by oncology drugs at 13.9% and central nervous system drugs ... Read More
Research Assistance
